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Hypoxic tumors are resistant to conventional therapies through indirect mechanisms such as the selection of resistant
phenotype under chronic hypoxia. Hyperbaric oxygen (HBO) therapy has been shown to increase oxygen level and induce
apoptosis in hypoxic tumor. However, it could produce signiﬁcant adverse effects including oxygen toxic seizures and severe
radiation tissue injury due to high pressure. We have shown that repeated oxygenation at 30% O2 (1 atmospheres absolute)
resultsinsigniﬁcantregressionofMCF-7tumorxenograftswithoutanyadverseeffect.InMCF-7cells,re-oxygenationshowedan
eightfold increase in cellular apoptosis. Both in hypoxic tumor and in hypoxic cells, that exclusively favor p53 to exist in mutant
conformation, re-oxygenation restores p53 wild-type conformation. The oxygen-mediated rescue of mutant p53 followed by
its trans-activation is responsible for the induction of p53-downstream apoptotic, cell-cycle arrest and DNA-repair genes.
Further, p53 trans-activation may thus be due to its post-translational modiﬁcations as a result of re-oxygenation. We have thus
concluded that oxygen therapy without pressure, as opposed to HBO therapy, may be ideal for hypoxic tumor regression, which
functions through oxygen-mediated rescue of mutant p53 followed by induction of apoptosis.
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Hypoxia is a physiological phenomenon commonly observed
in solid tumors, because oxygen levels ﬂuctuate in the
tumor microenvironment. Tumor hypoxia is associated with
increased invasion and metastatic potential thus making
tumor cells resistant to conventional therapy. Hyperbaric
oxygen (HBO) therapy,
1–3 a process that is characterized by
induced apoptosis, reduced vascular density and changes in
gene expression, was shown to increase pO2 levels in a
rat model causing signiﬁcant reduction in tumor growth,
4
by downregulating STAT3 and cyclin-D1 expressions.
5
However,hyperoxiaasaresultofHBOalsoproducesreactive
oxygen species, which increase sensitivity to seizures in rats
includingsevere radiationtissue injury;probably throughnitric
oxide synthase activation.
6,7 On the contrary, apoptosis was
signiﬁcantly suppressed in an inversely dose-dependent
manner at partial oxygen pressures below 10% in spermato-
cytes and spermatids.
8
Hypoxiaisknowntomodulatethep53pathway,inamanner
dependent or not of hypoxia induction factor-1, the severity
and the duration of hypoxia inﬂuence p53 protein level
and activity, in a cell-speciﬁc manner.
9 Cellular responses to
DNA-damage after hypoxia and re-oxygenation in cultured
human lymphocytes show that re-oxygenation following
hypoxia activates DNA-damage checkpoint signalling path-
ways that suppress cell-cycle progression inducing p53
expression and phosphorylation
10 of p53 at the serine15
residue. Further, oxygen induces S-phase growth arrest and
increases p53 and p21
WAF1/CIP1 expression in human
bronchial smooth-muscle cells leading to oxygen-mediated
alterations in proliferation are time- and concentration-
dependent manner.
11 Hypoxia-induced p53 fails to trans-
activate its target genes; recently, we have established that
the cause of its non-functional status in hypoxic tumor is due
to its conformational change under low oxygen concentration.
Strikingly, WT p53 behaves as a molecular chaperone and
rescued mutant p53 in hypoxic tumors thus causing hypoxic
tumor regression.
12
As the selection of p53-defective cells has been described
as a consequence of cyclic hypoxia
13 and Wt p53 undergoes
conformational change in to mutant form under low oxygen
concentration, we asked if re-oxygenation at normobaric
pressure could trans-activate p53 and its downstream genes
in regressing of hypoxic tumor. In this study, we have shown
that re-oxygenation (30%, 1 atmospheres absolute (ATA))
resulted in a signiﬁcant regression of MCF-7 tumor xenografts
through p53-mediated apoptosis. Re-oxygenation restored
p53 wild-type conformation followed by activation of its
downstream genes in the hypoxic cancer cells. We conclude
thatthep53trans-activationmaybeduetooxygen-dependent
p53 post-translational modiﬁcations.
Result
Oxygenation induces apoptosis and tumor regression
in p53(þ/þ) hypoxic cancer cells. The degree of hypoxia
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www.nature.com/cddisin tumors is highly variable, with the PO2 generally
o10–30mmHg (1–3% O2) ,i nc o n t r a s tt oaP O 2 of
50–80mmHg in most normal tissues.
14 Lithium octa-n-butoxy-
2,3-naphthalocyanine (LiNc-BuO) microcrystals were used
for tissue oxygen measurements in MCF-7 tumor xenografts
in healthy nude mice by electron paramagnetic resonance
(EPR) oximetry. The hypoxic core region has 1.8mmHg O2
concentration (pO2) whereas the healthy (non-tumor) tissue
showed 21.2mmHgO2 (Figure 1a).
12 In order to determine
the minimal oxygen concentration (1 ATA) that might induce
highest degree of apoptosis in hypoxic MCF-7 cancer cells,
we exposed cells to hypoxia (1.8% O2, 72h) followed by
re-oxygenation at different O2 concentrations (10–100%)
and measured apoptosis (Figure 1b). The apoptotic proﬁle
of these re-oxygenated cells was analyzed by annexin
V staining. Re-oxygenation induced 64% apoptosis in
p53(þ/þ) MCF-7 cells between the oxygen range of
30 and 100% oxygen when compared with 45% cellular
apoptosis at 20% O2. Further 10% O2 induced a mere 8%
apoptosis in hypoxic MCF-7 cells (Figure 1c). The results
showed that 30% oxygen treatment induced eightfold
increase in cellular apoptosis in the hypoxic MCF-7 cells.
The effect of oxygen (re-oxygenation) on cellular apoptosis
was then analyzed in several cell lines with p53(þ/þ) and
( / ) status. Interestingly, the induction of oxygen-
dependent apoptosis was exclusively higher in p53þ/þ
(HepG2, 61%; UOS2, 59%; RKO, 65%) cells (Figure 1d).
On the other hand, the apoptosis in response to O2 in
p53 /  (Saos-2 and H1299) and p53 mutant cells (PC3 p53,
HeLa p53, DU145 p53, WRO, Lncap, T47D) was
substantially lower (8–18%) (Figure 1d), suggesting that the
observed oxygen-mediated apoptosis is p53 dependent. In
order to conﬁrm the role of p53 in re-oxygenation-induced
apoptosis in hypoxic cancer cells we used MCF-7 p53(þ/þ
and  / ) and HCT p53(þ/þ and  / ) system as described
previously by Gogna et al.
15 The results shows that the
apoptosis observed in MCF-7 p53(þ/þ) and HCT p53
(þ/þ) cells was signiﬁcantly high as compared with the
MCF-7 p53( / ) and HCT p53( / ) cells (Figure 1e). It is
thus suggested that re-oxygenation-induced apoptosis in
hypoxic cancer cells is dependent on the presence of Wt p53
in these cells.
The observed role of oxygen in apoptosis in p53(þ/þ)
cancer cells led us to study the regression of hypoxic MCF-7
p53(þ/þ), MCF-7 p53( / ), HCT p53(þ/þ) and HCT
p53( / ) tumors through re-oxygenation. The tumor xeno-
graftswere grownonthe hindlegofnude miceandthe tumors
were treated with cisplatin for 20 days as control. The mice
bearing tumors were then exposed to 50% O2, 1 ATA, for 3h
per day for 20 days. The results showed that re-oxygenation
induced 77% and 80% tumor regression in MCF-7 p53(þ/þ)
and HCT p53(þ/þ) tumors, whereas only 23% and
20% tumor regression was observed in re-oxygenated
MCF-7 p53( / ) and HCT p53( / ) tumors, respectively
(Figure 2a). These data establish the crucial role of p53 in
tumor regression via re-oxygenation. We further analyzed if
thetumorregressioninhypoxictumorswasduetoinductionof
apoptosis in the tumor xenografts using the SR FLIVO in-vivo
apoptosis kit. The FLIVO was injected intravenously in to
nude mice bearing MCF-7 p53(þ/þ), MCF-7 p53( / ),
HCT p53(þ/þ) and HCT p53( / ) tumors post the
re-oxygenation therapy. The tissue was extracted and the
cells were trypsinized for ﬂow-cytometric analysis of cellular
apoptosis. The results showed 74.4% and 76.1% apoptosis in
the re-oxygenated MCF-7 p53(þ/þ) and HCT p53(þ/þ)
tumors, whereas only 22% and 24% apoptosis was observed
in the MCF-7 p53( / ) and HCT p53( / ) tumors, respec-
tively (Figure 2b). This data established that re-oxygenation
induces apoptosis in the hypoxic tumor tissue via a
p53-dependent mechanism.
Oxygen enhances p53 transactivation in hypoxic cancer
cells. As p53(þ/þ) tumors are more responsive to oxygen-
induced apoptosis, we analyzed the transcriptional activity of
p53 in hypoxic and re-oxygenated H1299 cells. Luciferase
constructs carrying p53-DBS of 30 p53 downstream gene
promoters that are involved in cell-cycle arrest and apoptosis
were transfected in H1299 cells along with wild-type p53
cDNA. The results showed that luciferase activity and thus
p53-mediated transcription at these promoters were absent
under hypoxic conditions (red bar). On re-oxygenation
(30%, 1 ATA), the luciferase activities were signiﬁcantly
increased (blue bar), and the highest activities were noticed
in cell-cycle arrest and DNA-repair genes (Figure 3a). The
results suggested that hypoxia-mediated inhibition of p53
downstream genes trans-activation was evoked through
re-oxygenation. The expression proﬁles of genes involved
in cellular apoptosis were analyzed both in hypoxic and
oxygen-treated MCF-7 cancer cells. Real-time PCR analysis
of 84 key genes involved in p53-dependent programmed cell-
death was conducted using human Apoptosis RT
2 Proﬁler
PCR Array (Figure 3b). The list of genes analyzed is provided
in Supplementary Table ST1. The results showed that in
hypoxic MCF-7 cells the genes that are involved in cellular
apoptosis were switched off (upper panel, green). On the
other hand, re-oxygenation showed signiﬁcant increase in
the expression of all the apoptotic genes in the array (lower
panel, red). Further, western blot analysis was conducted to
compare the expression of major p53-regulated apoptotic
proteins in hypoxic and re-oxygenated cancer cells
(Figure 3c). The results showed that the expression of
p53-regulated bax, apaf-1, puma, bad, bag-1, pig3, bak1,
caspase-3, p53 aip-1, pten-10 and tnfsf-10 was very low in
hypoxic MCF-7 cancer cells (Figure 3c, lane 2). However,
on re-oxygenation there was a substantial increase in the
expression of these p53-regulated apoptotic genes
(Figure 3c, lane 3).
Re-oxygenation restores p53 wild-type conformation
and p53 post-translational modiﬁcations. Under stress
conditions, Wt-p53 is known to exist in mutant conformation
that lacks DNA-binding function. As p53 is known to be
transcriptionally inactive under hypoxia
16 and re-oxygenation
showed signiﬁcant reduction in tumor growth through
induction of p53-downstream apoptotic genes, we deter-
mined whether oxygen could restore p53 transactivation
function in hypoxic core of MCF7 tumor via restoration of its
wild-type conformation. The effect of oxygen treatment on
the conformational status of p53 under in-vivo conditions
was analyzed. The hypoxic core tissues from the hypoxic
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Cell Death and Disease(control), cisplatin-treated and re-oxygenated MCF-7 tumor
xenografts were excised and the p53 wild-type (1620) and
mutant (240) conformations were analyzed using IPP with
p53 conformational antibodies (Figure 4a). Simultaneously,
the ratio of the 1620 and 240 forms of p53 was analyzed in
the control, cisplatin-treated and the re-oxygenated MCF-7
p53(þ/þ) and HCT p53(þ/þ) solid tumors (Figure 4b).
The hypoxic zones of the solid tumors contain p53 in mutant
(240) form. Cisplatin treatment was not effective in increasing
the 1620 form of p53 whereas re-oxygenation of hypoxic
tumors resulted in signiﬁcant rescue of the p53 1620 form in
both MCF-7 and HCT tumors. The results showed that p53
Figure 1 Re-oxygenation induces p53-dependent apoptosis in cancer cells. (a) The oxygen concentration in the peripheral and the core tissue regions of the MCF-7
tumors (approximately 2.2cm
3) were analyzed using EPR oximetry. The tumor core tissue shows 1.8mmHg pO2, whereas the peripheral tumor tissue shows 14.2mmHg
pO2. The healthy non-tumor tissue shows 21.2mmHg pO2 (n¼5).
12 *Po0.0148. (b) Cellular apoptosis is observed in hypoxic MCF-7 cells, which were re-oxygenated for
24h at 10–100% oxygen concentration. Results show signiﬁcant apoptotic fraction in hypoxic MCF-7 cells exposed to 30–100% oxygen (n¼10, S.D., ANOVA). *Po0.042.
(c) Annexin V staining of hypoxic MCF-7 cells shows signiﬁcant increase in the apoptotic fraction of the hypoxic MCF-7 cells on re-oxygenation with 30% oxygen (n¼10). (d)
Theeffectofre-oxygenation(30%O2)isobservedonthecellularapoptoticfractionofvariouscancercelllineswithp53(þ/þ)andp53( / )status.Theresultsshowthatre-
oxygenationinduceshigherapoptosisincancercellswithwild-typep53(n¼10,S.D.,ANOVA).*Po0.022.(e)Theroleofp53inre-oxygenation-inducedapoptosisinhypoxic
cancer cells using the MCF-7 p53(þ/þ), MCF-7 p53( / ) and HCT p53(þ/þ), HCT p53( / ) system. The results show that re-oxygenation induces 64 and 57%
apoptosis in MCF-7 p53(þ/þ), HCT p53(þ/þ) cells. On the other hand a mere 17 and 21% apoptosis is observed in the MCF-7 p53( / ), HCT p53( / ) cells.
*Po0.037
Re-oxygenation restores Wt-p53
R Gogna et al
3
Cell Death and Diseaseexists in mutant conformation in hypoxic tumors; cisplatin
treatment is not effective in restoration of the p53 1620
conformation, however, re-oxygenation alone signiﬁcantly
increased in the wild-type (1620) conformation. Further
the role of oxygen in rescue of p53 wild-type conformation
in hypoxic cultured H1299 cells (p53 / ) was analyzed after
transfection of Wt p53 cDNA in these cells, using
immunoprecipitation (Figure 4c). H1299 cells were cultured
in hypoxia chamber for 72h and the levels of (1620) and
(240) conformation were analyzed. In normoxic conditions,
p53 (1620) and p53 (240) forms existed in a near 1:1 ration.
The brief hypoxia shock of 8h stabilized the p53 1620 form.
At 54h, p53 was exclusively present in mutant conformation
whereas after subjecting the cells to 30% oxygen (1 ATA)
rapid rise in (1620) level and a fall in (240) level were
observed. The results suggested that the rise in transcri-
ptionally active p53 because of re-oxygenation is responsible
for induction of p53 downstream genes, and consequently,
apoptosis resulting in tumor regression. We then wanted
to know whether re-oxygenation might alter the status of
p53 phosphorylation and acetylation in inducing p53
transcriptional activity. The analysis of all p53 serine,
threonine and lysine residues, which may undergo phospho-
rylation and acetylation, was conducted through immuno-
precipitation using antibodies against phosphorylated
Ser
6, 9, 15, 20, 33, 37, 46, 315 and 392, phosphorylated Thr
18, 55,
81, 155 and 377 and acetylated Lys
120, 164, 305, 320, 373, 379 and 382
residues. Hypoxic MCF-7 cells showed minimal
phosphorylation at Ser
6, 9, 15 and acetylation at Lys
379, 382
residues (Figure 4d). On re-oxygenation the proﬁle of p53
post-translational modiﬁcations was signiﬁcantly altered and
p53 was phosphorylated and acetylated at all the known Ser,
Thr and Lys residues (Figure 4d). This data conﬁrmed that
oxygen-induced p53 transcriptional activity and p53 post-
translational modiﬁcations may be linked and that
oxygenation induces apoptosis in hypoxic cancer cells
by rescuing p53 transcriptional activity via alteration of p53
post-translational modiﬁcation pattern.
Discussion
In this study, we have shown that normobaric (1 ATA)
re-oxygenation (50% in vivo and 30% in vitro) is sufﬁcient to
induce apoptosis in various p53(þ/þ) and p53( / ) cancer
cells although the response to oxygen was signiﬁcant in
p53(þ/þ) cells. p53(þ/þ) cells were earlier shown to have
better response to chemo- and radiotherapy.
17,18 In general,
hypoxic cells are more resistant to chemo- and radiotherapy
treatmentthanwell-oxygenatedcells.Itwassuggestedearlier
that the abundance of cells at intermediate hypoxia, that is,
pO2 0.5–20mmHg, causes the resistance of tumors to
radiotherapy
19 although hypoxia and re-oxygenation are
necessary for lysyl-oxidase catalytic activity, which was
shown to facilitate cancer cell migration through a hydrogen
peroxide-mediated mechanism.
20 Re-oxygenation (50%) was
shown to regress MCF-7 tumor xenograft (63%) through the
restoration of p53 wild-type conformation which, in turn,
caused induction of p53-downstream apoptotic, cell-cycle
arrest and DNA-repair genes. Oxygen-mediated p53
conformational change that leads to its transactivation and
induction of genes in regression of tumor is an interesting
observation in this study.
Re-oxygenation was further responsible for inducing
p53 post-translational modiﬁcations, which may be the prime
cause of p53 trans-activation. It is established that p53
transcriptional activity is dependent on the status of p53
post-translational modiﬁcations.
20,21 Although phosphoryla-
tion of ser
6, ser
9, ser
37, ser
46 was reported earlier under
hypoxic condition,
21 our results show that there was no
phosphorylation of ser
37 and ser
46 at 1.8% oxygen, which
conﬁrms that p53 phosphorylation is dependent on O2 level in
hypoxia. Further, oxygenation plus cisplatin has an edge
over oxygenation in regard to the level of rescued p53. In
conclusion, normobaric oxygenation at low ATA, in contrast to
HBO,with orwithout chemotherapeuticmay bethe safestand
effective strategy for p53þ/þ tumor regression as oxygen is
shown to restore p53 function in hypoxic tumor. Future work
would focus on the mechanism of p53 conformational change
under deprived oxygen in the hypoxic core of solid tumors.
Figure 2 Re-oxygenation induces p53-dependent apoptosis in hypoxic tumors.
(a) The volume of hypoxic MCF-7 p53(þ/þ), MCF-7 p53( / ), HCT p53(þ/þ)
and HCT p53( / ) tumor xenografts is measured after treatment with cisplatin and
re-oxygenation. Results show that cisplatin treatment does not cause any signiﬁcant
change in the tumor size. The re-oxygenation treatment induces 475% tumor size
reduction in both MCF-7 p53(þ/þ)a n dH C Tp 5 3 (þ/þ) tumors. On the other
hand, re-oxygenation of MCF-7 p53( / ) and HCT p53( / ) tumors led to only
22and24%tumorregression(n¼8,S.D.,ANOVA).*Po0.034.(b)In-vivoapoptosis
kitfromFLIVOisusedtoanalyzeifthere-oxygenation-inducedtumorregressionisvia
apoptosis. The results show that re-oxygenation induces 475% apoptosis in both
MCF-7 p53(þ/þ) and HCT p53(þ/þ) tumors and only 22 and 24% in MCF-7
p53( / ) and HCT p53( / )t u m o r s( n¼8, S.D. ANOVA). *Po0.027
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Cell Death and DiseaseMaterials and Methods
Cell culture and transfections. HepG2, UOS2, RKO, Saos-2, H1299, PC3,
HeLa, DU145, WRO, Lncap, and T47D, MCF-7 and HCT cells lines were obtained
fromNationalCentre for CellSciences (Pune, India). The cell lines were maintainedin
DMEM medium supplemented with 10% FBS. All the transfections were carried
out using Effectene transfection reagent (Qiagen, Valencia, CA, USA) according to
manufacturer’s instructions.
Cell culture for tumor induction. MCF-7, a human breast cancer cell line,
was maintainedin DMEM/F12 supplemented with 10% FBS and 1% antibiotics.For
injection, cell at 70–90% conﬂuency were trypsinized and re-suspended in serum-
free medium with 1:1 Matrigel at a concentration of 1 10
7 cells/ml on ice. Cell
viability, 495%, was determined by Trypan blue exclusion assay.
Annexin V staining. Beckton Dickinson (Franklin Lakes, NJ, USA) ﬂow
cytometer was used to detect the apoptotic cell surface shift of phosphatidylserine
by the binding of ﬂuorescein isothiocyanate (FITC)-conjugated annexin V to the
outer membrane of intact cells. Floating cells were collected by centrifugation and
these, as well as the attached cells were washed in phosphate-buffered saline
(PBS) (Ca
2þ or Mg
2þ free)/0.1% EDTA. The attached cells were gently be
scraped off the dish, without trypsin digestion and the ﬂoating and attached cell
populations were combined, by centrifugation. After centrifugation, the cells were
incubated with 500ml binding buffer (Abcam, Cambridge, MA, USA) then 5mlo f
annexinV-FITCand5mlpropidiumiodidewasadded.Cellswereincubatedatroom
temperature for 5min. These cells were then ﬁltered through 70m mesh, to
eliminate cell aggregates and analyzed by ﬂow cytometry.
Figure 3 Re-oxygenation increases expression of p53 downstream genes. (a) Hypoxic and re-oxygenated cancer cells were transfected with luciferase cDNA constructs
carrying p53 DNA-binding sites. Results show that p53 is unable to increase luciferase activity at the promoters of its downstream genes in hypoxic cancer cells (black bar).
On re-oxygenation of the hypoxic cancer cells the luciferase activity of p53 downstream genes is signiﬁcantly increased (blue bar) (n¼11, S.D. ANOVA). (b) Real-time PCR
using the apoptotic gene array kit from SA Biosciences (Valencia, CA, USA) shows that p53 downstream apoptotic genes were negatively regulated in hypoxic cancer cells
(upperpanel).Whereas theexpression of thesegeneswas signiﬁcantlyhigherin re-oxygenated cancercells(lowerpanel)(n¼12).(c)Expressionofproteins involvedinp53
apoptotic pathway bax, apaf-1, puma, bad, bag-1, pig-3, bak-1, caspase-3, p53aip-1, pten-10 and tnfsf10 is analyzed in hypoxic (lane 2) and re-oxygenated (lane 3) cancer
cells (n¼10). Re-oxygenation-induced signiﬁcant increase in the expression of these proteins
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Cell Death and DiseaseEPR oximetry. LiNc-BuO microcrystals
22 were used for tissue oxygen
measurements. LiNc-Buo microcrystals (10mg) were suspended in 500-ml
DMEM. A 25-ml aliquot of this suspension was added to 10
5 MCF-7 cells for
each100-ml injection.Oxygenmeasurementswereperformedimmediately,weekly,
and on killing using an L-band EPR spectrometer (Magnettech, Berlin, Germany).
EPR spectra were acquired as single 30-s scans. The instrument settings were as
follows: incident microwave power, 4mW; modulation amplitude, 180mG;
modulation frequency, 100kHz; receiver time constant, 0.2s. The peak-to-peak
width of the EPR spectrum was used to calculate pO2 using a standard calibration
curve, as reported.
22
Animal and diet. Separate batches (for eight separate experiments) of
BALB/c nu/nu, athymic mice (n¼10 per experiment, aged 5 to 6 weeks old) were
maintained in micro-isolator cages (2 per cage) within a pathogen-free isolation
facility with 12-h light–dark cycle at 22 to 241C and 50% humidity. The basal diet
(BD) was based on the AIN-93G formulation, modiﬁed to have a high fat content
(20% corn oil) at the expenseof corn starch. TheFS diet was theBD supplemented
with 10% freshly ground FS corrected for the contribution of FS to fat, ﬁber and
protein components so that the energy values of the diets were maintained.
Tumor induction. A 80-ml cell suspension containing 1 10
7 cells was
subcutaneously injected into the hind legs of each mice, thus producing two sites of
MCF-7 tumor per mouse. Tumor volumes were monitored weekly by calliper
measurement of the length, width and height and were calculated using the formula
for a semi-ellipsoid (4/3pr
3/2). After 3 weeks, mice bearing tumors with volumes
averagingapproximately200mm
3wererandomizedfortreatment.Asaresultofthe
variations in tumor take and initial tumor growth as well as the removal of mice for
analysis at various time points, the number of mice at each time point varied from
experiment to experiment. The number of mice analyzed is reported in the text.
Tumor regression. The size of the tumors were carefully monitored after
the treatments using vernier calliper measurement of the length, width and height
and were calculated using the formula for a semi-ellipsoid (4/3pr
3/2).
Figure 4 Re-oxygenation increases p53 post-translational modiﬁcations. Re-oxygenation converts mutant p53 to wild-type p53. (a) The p53 wild-type and mutant
conformation were analyzed in hypoxic core tissue of control and treated MCF-7 tumor xenografts. Results show that p53 exists in a mutant conformation in hypoxic tumors.
Cisplatintreatmentisnoteffectiveinrestorationof p53(1620)conformationinthehypoxiczonesofthesolidtumors.Onre-oxygenation ofthetumorsthewt p53conformation
showeda signiﬁcantincrease,andhigherrateoftheconversionof mutantp53to wt p53(n¼7).(b) Theratio of p531620andp53240formwas analyzedinthehypoxiccore
tissue of MCF-7 p53(þ/þ) and HCT p53(þ/þ) tumors using in-vivo ELISA. The results show that re-oxygenation improves the p53-1620/p53-240 ratio and helps in
synthesis of p53 1620 form. (c) The effect of re-oxygenation on the conversion of mt p53 to wt p53 is observed in hypoxic H1299 cells transfected with Wt p53 cDNA.
IPPshowedthatat0h(i.e.normoxia)p531620andp53240formare presentinequalration(lanes3and4).Afterabrief hypoxicshockof 8h, thep531620formisstabilized
(lanes5and6).Afterachronichypoxiaexposureof54h,thep531620conformationislostandp53existsas240-conformation(lanes7and8).MCF-7cellsarere-oxygenated
after54hofhypoxiaand6hafterre-oxygenation(60-hmark)p53conformationisrevivedandIPPshowedincreasein1620form(lane3).p53wild-typeconformationshowed
consistentrisewithre-oxygenationandat72hmarkp53ismostlypresentin1620form(n¼8).(d)Thephosphorylationofp53atSer
6, 9, 15, 20, 33, 37, 46, 315 and 392,Thr
18, 55, 81,
155 and 377 and acetylation of p53 at Lys
120, 164, 305, 320, 373, 379 and 382 is analyzed using immunoprecipitation. Hypoxia abolishes p53 phosphorylation and acetylation whereas
re-oxygenation induces phosphorylation and acetylation at p53 core domain along with p53 N and C termini (n¼7)
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Cell Death and DiseaseApoptosis in tumorsamples. The cellular apoptosis in the tumors showing
regressiononre-oxygenationwasmeasuredusingRedSRFLIVOin-vivoapoptosis
staining kit (Immuno Chemistry Technologies USA, Bloomington, MN, USA) with
ﬂow-cytometry analysis.
Protein ELISA. The wells of a PVC microtiter plate were coated with polyclonal
antibodies at a concentration of 1–10mg/ml in carbonate/bicarbonate buffer
(pH 7.4). The plate was covered with an adhesive plastic and incubated overnight at
41C.Next,thecoatingsolutionwasremovedandtheplatewaswashedtwicebyﬁlling
thewellswith200mlPBS.Thesolutionsorwasheswereremovedbyﬂickingtheplate
overasink.Theremainingdropswereremovedbypattingtheplateonapapertowel.
Theremainingprotein-bindingsitesinthecoatedwellswereblockedbyadding200ml
blocking buffer, 5% non-fat dry milk/PBS, per well. Again the plate was covered with
an adhesive plastic and incubated overnight at 41C. In all, 100ml of appropriately
diluted cell suspension was added to each well and incubated for 90min at 371C. In
total, 100ml (0.5mg/100ml) of diluted detection antibody (monoclonal) was added to
each well. The plate was covered with an adhesive plastic and incubated for 2h at
room temperature. The plates were washed four times with PBS and 100mlo f
secondary antibody conjugated with horseradish peroxidase was added to the plate.
The plate was covered with an adhesive plastic and incubated for 1–2h at room
temperature. The plate was washed four times with PBS.
Preparation of lysates from tumor xenografts. The tissue of interest
was dissected with clean tools, on ice preferably and as quickly as possible to prevent
degradation by proteases. The tissue was placed in round bottom microfuge tubes and
was ‘snap-freezed’ by immersing it in liquid nitrogen. The samples were stored at
 801C for later use or kept on ice for immediate homogenization. In all, 300ml of lysis
buffer wasrapidlyaddedtothetubefora5mgpieceoftissueandhomogenizedwithan
electric homogenizer. The blade was rinsed twice with another 300ml lysis buffer. The
samples were then maintained at constant agitation for 2h at 41C. The samples were
centrifuged for 20min at 12000r.p.m. at 41C in a micro-centrifuge. The tubes were
gently removed from the centrifuge and placed on ice, the pellet was discarded and the
supernatant was aspirated and placed in a fresh tube kept on ice.
Luciferase assay. Cells were plated in 35mm Petri dishes the day before
transfection so that they reached 60–80% conﬂuence on transfection. Reporter plasmids
(carrying p53 downstream genes DBS in PGL2 vector (1.0–1.5mg per well) were
transfected with effectene transfection reagent (Qiagen) as per the manufacturer’s
instructions.Afterdesiredincubationperiod,thecellswerewashedincoldPBSthreetimes
andlysedwith200mlofthelysisbufferbyafreeze–thawcycle,andlysateswerecollected
by centrifugation at 14000r.p.m. for 2min in a bench top centrifuge. Twenty micro-liter of
supernatant was used for the assay of luciferase activity using a kit (Promega, Madison,
WI, USA) as per the manufacturer’s instruction.
Human apoptosis PCR array. The Human Apoptosis RT
2 Proﬁler PCR
Arraykit(PAHS-012)was used to proﬁletheexpressionof 84 key genes involvedin
programmed cell death.
Immunoprecipitation. To assay the p53 conformation in treated cells, the
cells and the tissue samples were washed three times in ice-cold PBS and lysed in
500ml (per 10-cm-diameter dish) of NP-40 lysis buffer (100mM NaCl, 100mM Tris
(pH 8.0), 1% NP-40) supplemented with proteasome inhibitors (Complete inhibitor
mix; Boerhinger Mannheim, Ridgeﬁeld, CT, USA) for 30min at 41C. p53 protein
was immunoprecipitated overnight at 41C by incubation with PAb240 and
PAb1620-protein A-Sepharose beads equilibrated in NP-40 lysis buffer. The
immunoprecipitated protein was washed three times with NP-40 lysis buffer, and
samples were re-suspended in 50mlo f2  sodium dodecyl sulfate (SDS) sample
buffer, incubated at room temperature for 10min and then assayed by SDS-10%
polyacrylamide gel electrophoresis. Western blots were probed with either anti-
p531801 or anti-p53421 antibodies. Additionally, western blot analysis to assess
p53 protein levels in whole-cell extracts was performed in parallel using PAb1801.
Western blotting. Whole-cell lysates were prepared using RIPA buffer
(10mM Tris-HCl (pH 7.4), 150mM NaCl, 1% NP-40, 1mM EDTA, 0.1% SDS, and
1mM DTT). Proteins were resolved by 10% or 12% SDS-PAGE and transferred
onto PVDF membranes (Invitrogen, Grand Island, NY, USA). Incubations with
primary antibodies were followed by incubations with the appropriate secondary
antibodies (Amersham, Piscataway, NJ, USA) and detection by DAB substrate
development kit from (Vector Lab, Burlingame, CA, USA). To quantify western
blotting signals, densitometry was performed using the software ImageJ (NIH,
Bethesda, MD, USA).
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